Security key
00032Q104
Whitehawk Therapeutics, Inc. - Common Stock (WHWK)
CUSIP: 00032Q104
Q4 2021 13F Holders as of 31 Dec 2021
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 12,184,052
- Total 13F value
- $294,238,682
- Share change
- +1,087,157
- SEC-reported price per share
- $24.15
- Number of holders
- 44
- Value change
- +$23,944,526
- Number of buys
- 28
- Number of sells
- 10
- Shares outstanding
- 53,819,722
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2021
Institutions
44
Top holders
10
WHWK full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Whitehawk Therapeutics, Inc. SEC filings
Whitehawk Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00032Q104
Recent filing periods:
Ownership snapshot
Top reported holders of WHWK - Whitehawk Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Avoro Capital Advisors LLC
Disclosed value leader
Avoro Capital Advisors LLC
Comparable rows
15/15
Latest evidence
30 Sep 2021
13F
Lead comparable stake: 3.4%
Showing 1-6 of 15 holder rows.
Quick read
Avoro Capital Advisors LLC leads the comparable SEC ownership view at 3.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Avoro Capital Advisors LLC's linked filing trail.
Comparable ownership
Top 5
Avoro Capital Advisors LLC
3.4%
ACUTA CAPITAL PARTNERS, LLC
2.8%
Venrock Adviser, LLC
2.8%
Vivo Capital, LLC
2.7%
BVF INC/IL
2.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Avoro Capital Advisors LLC |
13F
Company
|
3.4%
|
$53,730,000
1,829,402 shares
|
— | 30 Sep 2021 |
| ACUTA CAPITAL PARTNERS, LLC |
13F
Company
|
2.8%
|
$44,919,000
1,529,402 shares
|
— | 30 Sep 2021 |
| Venrock Adviser, LLC |
13F
Company
|
2.8%
|
$44,919,000
1,529,402 shares
|
— | 30 Sep 2021 |
| Vivo Capital, LLC |
13F
Company
|
2.7%
|
$41,917,000
1,427,213 shares
|
— | 30 Sep 2021 |
| BVF INC/IL |
13F
Company
|
2.1%
|
$33,689,000
1,147,052 shares
|
— | 30 Sep 2021 |
| Rock Springs Capital Management LP |
13F
Company
|
1.4%
|
$22,459,000
764,701 shares
|
— | 30 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
44
Shares
12,184,052
Rows available
44
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q4 2025 Across Filers
Q4 2025 holders
47
Q4 2021 holders
44
Holder diff
-3
| Investor | Q4 2025 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q4 2025 value | Q4 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend